相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
Egle Ramelyte et al.
CANCER CELL (2021)
Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment
Tan-Trieu Nguyen et al.
CLINICAL CANCER RESEARCH (2021)
Metabolic modulation of tumours with engineered bacteria for immunotherapy
Fernando P. Canale et al.
NATURE (2021)
Computation-guided optimization of split protein systems
Taylor B. Dolberg et al.
NATURE CHEMICAL BIOLOGY (2021)
T cell circuits that sense antigen density with an ultrasensitive threshold
Rogelio A. Hernandez-Lopez et al.
SCIENCE (2021)
Model-guided design of mammalian genetic programs
J. J. Muldoon et al.
SCIENCE ADVANCES (2021)
Can Biomarkers Guide Oncolytic Virus Immunotherapy?
Howard L. Kaufman
CLINICAL CANCER RESEARCH (2021)
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
Axel Hyrenius-Wittsten et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
CAR-T cells: Early successes in blood cancer and challenges in solid tumors
Hassan Dana et al.
ACTA PHARMACEUTICA SINICA B (2021)
Oncolytic Virotherapy for Cancer: Clinical Experience
Shyambabu Chaurasiya et al.
BIOMEDICINES (2021)
Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease
Benjamin M. Scott et al.
NATURE MEDICINE (2021)
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study
Marja K. Puurunen et al.
NATURE METABOLISM (2021)
The COMET toolkit for composing customizable genetic programs in mammalian cells
Patrick S. Donahue et al.
NATURE COMMUNICATIONS (2020)
Design and Characterization of an All-in-One Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
Katharina Zimmermann et al.
CANCERS (2020)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Mark R. Charbonneau et al.
NATURE COMMUNICATIONS (2020)
Self-restoration of cardiac excitation rhythm by anti-arrhythmic ion channel gating
Rupamanjari Majumder et al.
ELIFE (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Engineered T cells directed at tumors with defined allelic loss
Agnes E. Hamburger et al.
MOLECULAR IMMUNOLOGY (2020)
Negative feedback control of neuronal activity by microglia
Ana Badimon et al.
NATURE (2020)
Synthetic immunomodulation with a CRISPR super-repressor in vivo
Farzaneh Moghadam et al.
NATURE CELL BIOLOGY (2020)
Combining mechanistic and machine learning models for predictive engineering and optimization of tryptophan metabolism
Jie Zhang et al.
NATURE COMMUNICATIONS (2020)
EpiMogrify Models H3K4me3 Data to Identify Signaling Molecules that Improve Cell Fate Control and Maintenance
Uma S. Kamaraj et al.
CELL SYSTEMS (2020)
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Maisa C. Takenaka et al.
NATURE NEUROSCIENCE (2019)
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Praveen K. Bommareddy et al.
ONCOIMMUNOLOGY (2019)
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III- IV melanoma
Robert H. Andtbacka et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways
Bing Huang et al.
CELL (2019)
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
Huiya Huang et al.
NATURE COMMUNICATIONS (2019)
An engineered E-coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
Caroline B. Kurtz et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens
Michele Proietti et al.
NATURE COMMUNICATIONS (2019)
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Synthetic bottom-up approach reveals the complex interplay of Shigella effectors in regulation of epithelial cell death
Xiangyu Mou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention
Chun Loong Ho et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Vincent M. Isabella et al.
NATURE BIOTECHNOLOGY (2018)
MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation
Praveen K. Bommareddy et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Praveen K. Bommareddy et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Rewiring human cellular input-output using modular extracellular sensors
Kelly A. Schwarz et al.
NATURE CHEMICAL BIOLOGY (2017)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas et al.
FRONTIERS IN IMMUNOLOGY (2017)
A modular yeast biosensor for low-cost point-of-care pathogen detection
Nili Ostrov et al.
SCIENCE ADVANCES (2017)
Escherichia coli surface display for the selection of nanobodies
Valencio Salema et al.
MICROBIAL BIOTECHNOLOGY (2017)
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
Fiona C. Thistlethwaite et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Regulation of inflammation by microbiota interactions with the host
J. Magarian Blander et al.
NATURE IMMUNOLOGY (2017)
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Kole T. Roybal et al.
CELL (2016)
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Leonardo Morsut et al.
CELL (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Kole T. Roybal et al.
CELL (2016)
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
Diane J. Schmidt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice
Mahtab Moayeri et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E-coli display
Valencio Salema et al.
MABS (2016)
A predictive computational framework for direct reprogramming between human cell types
Owen J. L. Rackham et al.
NATURE GENETICS (2016)
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
Veit Rothhammer et al.
NATURE MEDICINE (2016)
Comparison of Cas9 activators in multiple species
Alejandro Chavez et al.
NATURE METHODS (2016)
Regulation of the T Cell Response by CD39
Maisa C. Takenaka et al.
TRENDS IN IMMUNOLOGY (2016)
INSIGHTS FROM 100 YEARS OF RESEARCH WITH PROBIOTIC E. COLI
Trudy M. Wassenaar
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
Ivan D. Mascanfroni et al.
NATURE MEDICINE (2015)
Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells
David Ruano-Gallego et al.
ACS SYNTHETIC BIOLOGY (2015)
Engineering Escherichia coli into a Protein Delivery System for Mammalian Cells
Analise Z. Reeves et al.
ACS SYNTHETIC BIOLOGY (2015)
Adenovirus Vector Expressing Stx1/Stx2-Neutralizing Agent Protects Piglets Infected with Escherichia coli O157:H7 against Fatal Systemic Intoxication
Abhineet S. Sheoran et al.
INFECTION AND IMMUNITY (2015)
Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins
Carlos Pinero-Lambea et al.
ACS SYNTHETIC BIOLOGY (2015)
Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices
Nichole M. Daringer et al.
ACS SYNTHETIC BIOLOGY (2014)
Toll-like receptors and cancer: MYD88 mutation and inflammation
James Q. Wang et al.
FRONTIERS IN IMMUNOLOGY (2014)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39
Ivan D. Mascanfroni et al.
NATURE IMMUNOLOGY (2013)
Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: A nationwide cohort study in Taiwan
Chian-Yaw Hwang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
A Heritable Recombination System for Synthetic Darwinian Evolution in Yeast
Dante W. Romanini et al.
ACS SYNTHETIC BIOLOGY (2012)
Reiterative Recombination for the in vivo assembly of libraries of multigene pathways
Laura M. Wingler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Direct Injection of Functional Single-Domain Antibodies from E. coli into Human Cells
Ana Blanco-Toribio et al.
PLOS ONE (2010)
PCRless library mutagenesis via oligonucleotide recombination in yeast
Nathan Pirakitikulr et al.
PROTEIN SCIENCE (2010)
High-Throughput Selection for Cellulase Catalysts Using Chemical Complementation
Pamela Peralta-Yahya et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
ATP drives lamina propria TH17 cell differentiation
Koji Atarashi et al.
NATURE (2008)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Directed evolution of a glycosynthase via chemical complementation
HN Lin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Dexamethasone-methotrexate:: An efficient chemical inducer of protein dimerization in vivo
HN Lin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)